세계의 헤모글로빈 A1c(HbA1c) 검사 시장 보고서(2025년)

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c (hba1c) testing market size has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to $2.02 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing awareness and screening programs, growing government initiatives and healthcare policies, increasing healthcare infrastructure development, a growing aging population, improved diagnostic accuracy, and increased adoption of point-of-care testing.

The hemoglobin a1c (hba1c) testing market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle diseases, increased focus on preventive healthcare, expansion in emerging markets, increasing personalized medicine and patient-centric care, regulatory support and reimbursement policies, growing telemedicine, and remote monitoring. Major trends in the forecast period include technological advancements, integration with digital health platforms, advancements in non-invasive testing technologies, expansion in telehealth, and remote patient monitoring.

The forecast of 10.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder diabetes management by inflating prices of High-Performance Liquid Chromatography(HPLC) analyzers and point-of-care HbA1c test kits developed in Sweden and Canada, resulting in delayed glycemic control assessments and higher endocrinology testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin a1c (hba1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c (hba1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
• 2) By Product Type: Instruments; Reagents; Kits
• 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
• 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
• Subsegments:
• 1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing; Ion-Exchange Chromatography; Capillary Electrophoresis; Enzyme-Linked Immunosorbent Assay (ELISA); Mass Spectrometry
• 2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices; Portable Hba1c Analyzers; Handheld Hba1c Test Kits; Home Use Hba1c Monitoring Devices; Wireless Hba1c Testing Solutions
• Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers; Tosoh Corporation; Hitachi High-Technologies Corporation; Beckman Coulter Inc; Sysmex Corporation; Bio Rad Laboratories Inc; ARKRAY Inc; Randox Laboratories Ltd; Ortho Clinical Diagnostics; Agappe Diagnostics Ltd; SEKISUI Diagnostics LLC; Helena Laboratories; Transasia Bio Medicals Ltd; EKF Diagnostics; Trinity Biotech plc; HemoCue AB; CPC Diagnostics Pvt Ltd; PTS Diagnostics; Menarini Diagnostics srl; Diazyme Laboratories Inc; Osang HealthCare Co Ltd; Eurolyser Diagnostica GmbH; DiaSys Diagnostic Systems GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin A1c (HbA1c) Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hemoglobin A1c (HbA1c) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hemoglobin A1c (HbA1c) Testing Market Growth Rate Analysis
• 5.4. Global Hemoglobin A1c (HbA1c) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hemoglobin A1c (HbA1c) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hemoglobin A1c (HbA1c) Testing Total Addressable Market (TAM)

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

• 6.1. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Based Testing
• Point Of Care (Poc) Testing
• 6.2. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents
• Kits
• 6.3. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassays
• Chromatography
• Enzymatic Assays
• Boronate Affinity Chromatography
• High Performance Liquid Chromatography
• Other Technologies
• 6.4. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Homecare Settings
• Other End Users
• 6.5. Global Hemoglobin A1c (HbA1c) Testing Market, Sub-Segmentation Of Laboratory-Based Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Performance Liquid Chromatography (HPLC) Testing
• Ion-Exchange Chromatography
• Capillary Electrophoresis
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Mass Spectrometry
• 6.6. Global Hemoglobin A1c (HbA1c) Testing Market, Sub-Segmentation Of Point Of Care (PoC) Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fingerstick Testing Devices
• Portable Hba1c Analyzers
• Handheld Hba1c Test Kits
• Home Use Hba1c Monitoring Devices
• Wireless Hba1c Testing Solutions

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

• 7.1. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

• 8.1. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin A1c (HbA1c) Testing Market

• 9.1. China Hemoglobin A1c (HbA1c) Testing Market Overview
• 9.2. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin A1c (HbA1c) Testing Market

• 10.1. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin A1c (HbA1c) Testing Market

• 11.1. Japan Hemoglobin A1c (HbA1c) Testing Market Overview
• 11.2. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin A1c (HbA1c) Testing Market

• 12.1. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

• 13.1. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

• 14.1. South Korea Hemoglobin A1c (HbA1c) Testing Market Overview
• 14.2. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

• 15.1. Western Europe Hemoglobin A1c (HbA1c) Testing Market Overview
• 15.2. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin A1c (HbA1c) Testing Market

• 16.1. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin A1c (HbA1c) Testing Market

• 17.1. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin A1c (HbA1c) Testing Market

• 18.1. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin A1c (HbA1c) Testing Market

• 19.1. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin A1c (HbA1c) Testing Market

• 20.1. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

• 21.1. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market Overview
• 21.2. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin A1c (HbA1c) Testing Market

• 22.1. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin A1c (HbA1c) Testing Market

• 23.1. North America Hemoglobin A1c (HbA1c) Testing Market Overview
• 23.2. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin A1c (HbA1c) Testing Market

• 24.1. USA Hemoglobin A1c (HbA1c) Testing Market Overview
• 24.2. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin A1c (HbA1c) Testing Market

• 25.1. Canada Hemoglobin A1c (HbA1c) Testing Market Overview
• 25.2. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin A1c (HbA1c) Testing Market

• 26.1. South America Hemoglobin A1c (HbA1c) Testing Market Overview
• 26.2. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

• 27.1. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

• 28.1. Middle East Hemoglobin A1c (HbA1c) Testing Market Overview
• 28.2. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin A1c (HbA1c) Testing Market

• 29.1. Africa Hemoglobin A1c (HbA1c) Testing Market Overview
• 29.2. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

• 30.1. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape
• 30.2. Hemoglobin A1c (HbA1c) Testing Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

• 31.1. Tosoh Corporation
• 31.2. Hitachi High-Technologies Corporation
• 31.3. Beckman Coulter Inc
• 31.4. Sysmex Corporation
• 31.5. Bio Rad Laboratories Inc
• 31.6. ARKRAY Inc
• 31.7. Randox Laboratories Ltd
• 31.8. Ortho Clinical Diagnostics
• 31.9. Agappe Diagnostics Ltd
• 31.10. SEKISUI Diagnostics LLC
• 31.11. Helena Laboratories
• 31.12. Transasia Bio Medicals Ltd
• 31.13. EKF Diagnostics
• 31.14. Trinity Biotech plc
• 31.15. HemoCue AB

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

34. Recent Developments In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market High Potential Countries, Segments and Strategies

• 35.1 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer